Celiac Disease Foundation

Official account for the Celiac Disease Foundation, the leading global public voice for celiac disease. Follow ≠ endorsement

[Celiac Disease Foundation @CeliacDotOrg]

Better treatments for celiac disease are being developed! You can help us get there. AVALON is a clinical trial researching VTP-1000, an investigational immunotherapy designed to prevent or reduce symptoms from accidental gluten exposure. Learn more: https://t.co/L7DZKB3gPR

[Celiac Disease Foundation @CeliacDotOrg]

Celiac disease holding you back? Consider joining a clinical trial. Now enrolling adults with celiac disease in a research study testing the investigational drug TEV-53408 for celiac disease. Compensation may be available. Learn more: https://t.co/yAUnJ6qfuZ

[Celiac Disease Foundation @CeliacDotOrg]

What if you didn’t have to worry so much about cross-contact with gluten? Help advance better treatments for celiac disease. AVALON is enrolling adults ages 18–65 in the US with biopsy-confirmed celiac disease (other criteria apply). Learn more: https://t.co/L7DZKB3gPR #celiac

[Celiac Disease Foundation @CeliacDotOrg]

Consider joining a research study testing a potential drug for celiac disease. Now enrolling adults ages 18-65 who have been diagnosed with celiac disease and on a gluten-free diet for 12+ months. Compensation may be available. Learn more: https://t.co/yAUnJ6qfuZ

[Celiac Disease Foundation @CeliacDotOrg]

Explore AVALON, a phase 1 clinical trial studying an investigational drug designed to prevent/reduce celiac disease symptoms from accidental gluten exposure by promoting tolerance to gluten. Compensation for time and travel may be available. https://t.co/L7DZKB3gPR #CeliacDisease

[Celiac Disease Foundation @CeliacDotOrg]

Want to get involved in celiac disease research? It’s time to take action. You may qualify for the TEV-CeD2 Study, a research study testing an investigational drug for celiac disease. Compensation may be available. Learn more: https://t.co/yAUnJ6qfuZ

#celiac

[Celiac Disease Foundation @CeliacDotOrg]

Want to get involved in celiac disease research? It’s time to take action. You may qualify for the TEV-CeD2 Study, a research study testing an investigational drug for celiac disease. Compensation may be available. Learn more: https://t.co/yAUnJ6qfuZ

[Celiac Disease Foundation @CeliacDotOrg]

What if you didn’t have to worry so much about gluten cross-contact? Help advance better treatments for celiac disease. AVALON is enrolling adults ages 18–65 in the US with biopsy-confirmed celiac disease (other criteria apply). Learn more: https://t.co/L7DZKB3gPR #AVALONStudy

[Celiac Disease Foundation @CeliacDotOrg]

Celiac disease holding you back? Consider joining a clinical trial. Now enrolling adults with celiac disease in a research study testing the investigational drug TEV-53408 for celiac disease. Compensation may be available. Learn more: https://t.co/yAUnJ6qfuZ

[Celiac Disease Foundation @CeliacDotOrg]

This study is testing the investigational drug VTP-1000 for the potential treatment of celiac disease. Participants must be ages 18–65, biopsy-diagnosed with celiac disease, and on a gluten-free diet for 12+ months (other criteria apply). Learn more at https://t.co/L7DZKB3gPR

[Celiac Disease Foundation @CeliacDotOrg]

Consider joining a research study testing a potential drug for celiac disease. Now enrolling adults ages 18-65 who have been diagnosed with celiac disease and on a gluten-free diet for 12+ months. Compensation may be available. Learn more: https://t.co/yAUnJ6qfuZ

[Celiac Disease Foundation @CeliacDotOrg]

What if you didn’t have to worry so much about gluten cross-contact? Help advance better treatments for celiac disease. AVALON is enrolling adults ages 18–65 in the US with biopsy-confirmed celiac disease (other criteria apply). Learn more: https://t.co/L7DZKB3gPR #AVALONStudy

[Celiac Disease Foundation @CeliacDotOrg]

Want to get involved in celiac disease research? It’s time to take action. You may qualify for the TEV-CeD2 Study, a research study testing an investigational drug for celiac disease. Compensation may be available. Learn more: https://t.co/yAUnJ6qfuZ

[Celiac Disease Foundation @CeliacDotOrg]

Calling all celiac disease researchers! The Association of European Coeliac Societies (AOECS) announced its fourth call for scientific papers on research and innovation related to celiac disease. The submission deadline is September 5th, 2025. Learn more: https://t.co/hE1vWqcaN6

[Celiac Disease Foundation @CeliacDotOrg]

🌟 A new paper published in the Journal of Pediatric Gastroenterology and Nutrition outlines the next steps for general population screening for celiac disease in the U.S.: https://t.co/ySGIv27aep

#CeliacDisease #CeliacAwareness #Celiac #AutoimmuneDisease #GlutenFree

[Celiac Disease Foundation @CeliacDotOrg]

Explore AVALON, a phase 1 clinical trial studying an investigational drug designed to prevent or reduce celiac disease symptoms from accidental gluten exposure by promoting gluten tolerance. Compensation for time and travel may be available. https://t.co/L7DZKB3gPR #CeliacDisease

[Celiac Disease Foundation @CeliacDotOrg]

Explore AVALON, a phase 1 clinical trial studying an investigational drug designed to prevent or reduce celiac disease symptoms from accidental gluten exposure by promoting gluten-tolerance. Compensation for time and travel may be available. https://t.co/L7DZKB3gPR #CeliacDisease

[Celiac Disease Foundation @CeliacDotOrg]

What makes someone with celiac feel normal? For one guest on Celiac Cruise, it was simple: croutons.⁠ Not just any croutons—gluten-free croutons on their Caesar salad.⁠ Because it’s not just food. It’s feeling included.⁠

#CeliacCruise #Celiac #Glutenfree #GlutenFreeTravel

[Celiac Disease Foundation @CeliacDotOrg]

What makes people with celiac feel normal? For some, it’s piling a plate high with nachos—no questions asked.⁠ On Celiac Cruise, the late night buffet serves up fully gluten-free nachos, and the smiles say it all.⁠ Crunchy, cheesy, carefree.⁠ #CeliacCruise #GlutenFreeTravel

[Celiac Disease Foundation @CeliacDotOrg]

Have you ever thought about joining a clinical trial? Now is a great time to start! AVALON is researching a potential treatment for celiac disease, VTP-1000. Now enrolling US adults ages 18–65 with biopsy-confirmed celiac disease (other criteria apply). https://t.co/L7DZKB3gPR